Charles Schwab’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.02M | Buy |
|
|||||
|
2025
Q1 | $7.63M | Sell |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $11.7M | Buy |
|
|||||
|
2024
Q2 | $6.3M | Buy |
|
|||||
|
2024
Q1 | $7.43M | Buy |
|
|||||
|
2023
Q4 | $8.09M | Buy |
|
|||||
|
2023
Q3 | $4.8M | Buy |
|
|||||
|
2023
Q2 | $2.75M | Buy |
|
|||||
|
2023
Q1 | $2.65M | Buy |
|
|||||
|
2022
Q4 | $2.99M | Buy |
|
|||||
|
2022
Q3 | $1.51M | Buy |
|
|||||
|
2022
Q2 | $790K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $134K | Hold |
|
|||||
|
2018
Q4 | $146K | Hold |
|
|||||
|
2018
Q3 | $268K | Hold |
|
|||||
|
2018
Q2 | $308K | Buy |
|
|||||
|
2018
Q1 | $245K | Buy |
|
|||||
|
2017
Q4 | $223K | Hold |
|
|||||
|
2017
Q3 | $195K | Hold |
|
|||||
|
2017
Q2 | $276K | Buy |
|